<DOC>
	<DOC>NCT01991951</DOC>
	<brief_summary>We hypothesized that in patients with low CHADS-VASc score (2 or &lt; 2), there is no difference in thromboembolic or bleeding events between patients with short term warfarin therapy (2 weeks after catheter ablation) and conventional therapy (3 weeks before and 8 weeks after procedure).</brief_summary>
	<brief_title>Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients with paroxysmal atrial fibrillation who underwent radiofrequency catheter ablation Patients with CHADSVASc score 2 or less than 2 Patients who do not consent to the study Permanent or persistent atrial fibrillation Patients who have underwent prior catheter ablation for atrial fibrillation CHADSVASc score more than 2 History of stroke LVEF &lt;40% Significant liver or kidney dysfunction History of major bleeding during warfarin therapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>